200,000+ products from a single source!

sales@angenechem.com

Home > Other Heterocycles > 125481-61-0

125481-61-0

125481-61-0 | 8-Azaspiro[4.5]decane-7,9-dione, 6-hydroxy-8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-

CAS No: 125481-61-0 Catalog No: AG000NPO MDL No:

Product Description

Catalog Number:
AG000NPO
Chemical Name:
8-Azaspiro[4.5]decane-7,9-dione, 6-hydroxy-8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
CAS Number:
125481-61-0
Molecular Formula:
C21H31N5O3
Molecular Weight:
401.5025
IUPAC Name:
10-hydroxy-8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione
InChI:
InChI=1S/C21H31N5O3/c27-17-16-21(6-1-2-7-21)18(28)19(29)26(17)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9,18,28H,1-4,6-7,10-16H2
InChI Key:
KOZNAHJIJGCFJJ-UHFFFAOYSA-N
SMILES:
O=C1CC2(CCCC2)C(C(=O)N1CCCCN1CCN(CC1)c1ncccn1)O
UNII:
4PRI09E14U

Properties

Complexity:
581  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
401.243g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
401.511g/mol
Monoisotopic Mass:
401.243g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
89.9A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  

Literature

Title Journal
Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans. Biopharmaceutics & drug disposition 20071001
6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats. Drug metabolism and disposition: the biological fate of chemicals 20070801
Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range. Journal of clinical pharmacology 20061101

© 2019 Angene International Limited. All rights Reserved.